Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function Featured Article: Elif I. Ekinci, P.H.D.,

Slides:



Advertisements
Similar presentations
Drug therapy in renal failure Kari Laine, MD, PhD University of Turku & medbase Ltd.
Advertisements

Proteinuria as a Surrogate Outcome in Chronic Kidney Disease Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson,
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Lesley Stevens MD Tufts-New England Medical Center
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
RENAL DISEASE IN DIABETES
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:
Copyright ©2000 BMJ Publishing Group Ltd. Stratton, I. M et al. BMJ 2000; 321:
Section 2: Detection of CKD. What Tests Are Available? Direct GFR measurement –Inulin clearance –Radionuclides –Iohexol clearance 3 hr CrCl with Cimetidine.
La gestione del paziente diabetico: bisogni, percorsi e strumenti Metodi per lo studio della nefropatia Giuseppe Penno Dipartimento di Medicina Clinica.
DIABETIC NEPHROPATHY MADRAS DIABETES RESEARCH FOUNDATION, Gopalapuram, Chennai DIRECTOR & DIABETOLOGIST Dr.Mohan’s DIABETES SPECIALITIES CENTRE Dr. Mohan’s.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Diabetic nephropathy is a clinical syndrome.
Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes A Diffusion Tensor Imaging Study Featured Article: Yael D. Reijmer,
Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.
Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes Featured Article: Andrzej S. Krolewski, M.D., Ph.D., James H. Warram,
High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes Featured.
Updates in Diabetic Nephropathy Rodica Pop-Busui, M.D., Ph.D Division of Metabolism, Endocrinology and Diabetes Michigan Comprehensive Diabetes Center.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
The Relationship of Diabetic Retinopathy to Preclinical Diabetic Glomerulopathy Lesions in Type 1 Diabetic Patients The Renin-Angiotensin System study(RASS)
Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74 Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, Amanda I Adler,
Celiac Disease Increases Risk of Thyroid Disease in Patients With Type 1 Diabetes: A Nationwide Cohort Study Featured Article: Matthew Kurien, Kaziwe Mollazadegan,
Date of download: 9/16/2016 From: Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?:
The LIVES Sub-analysis
Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies  Richard.
The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes
Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy  Kantima Phisitkul, MD, Khaled Hegazy, MD, Temduang.
Estimated GFR in Diabetes
Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.
Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.
Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus by Francesca Viazzi, Pamela Piscitelli, Antonio.
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
Panelists. Type 2 Diabetes, Renal Impairment, and CHD: Reducing 2 Vascular Risks With 1 Stone.
The percentage of subjects with de novo development of renal function impairment (GFR
Volume 78, Issue 3, Pages (August 2010)
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Update on Diabetic Nephropathy: Core Curriculum 2018
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
‘Progressive diabetic nephropathy. How useful is microalbuminuria
Your Kidneys May Outlive You
Volume 72, Issue 10, Pages (November 2007)
(A) Kaplan-Meier renal survival estimates of patients with diabetic nephropathy (DN), non-diabetic renal disease (NDRD) and mixed groups, adjusting for.
Targets to retard the progression of diabetic nephropathy
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
A novel classification for IgA nephropathy
Statins and other agents for vascular inflammation
(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.
The effect of chronic renal insufficiency by use of glomerular filtration rate versus serum creatinine level on late clinical outcome of carotid endarterectomy 
Drug Dose Adjustments in Patients With Renal Impairment
(A through C) Mean eGFR during follow-up according to treatment assignment in patients with normoalbuminuria (A), microalbuminuria (B), and macroalbuminuria.
Validation of the Oxford classification of IgA nephropathy
Volume 66, Issue 3, Pages (September 2004)
(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.
Serum 25(OH)D levels stratified by the presence or absence of nephropathy. Serum 25(OH)D levels stratified by the presence or absence of nephropathy. The.
Pancreas Transplantation for the Prevention of Diabetic Nephropathy
Volume 60, Issue 1, Pages (July 2001)
Study protocol. Study protocol. Fourteen patients had research renal biopsies, and 17 patients with macroalbuminuria had renal biopsies for clinical reasons.
Mean mesangial area (micron2) across normal controls (normal C), patients with type 2 diabetes and normoalbuminuria (normo), patients with type 2 diabetes.
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Lipoprotein abnormalities in diabetic nephropathy
Kidney and hypertension
Relationship between time from diagnosis of type 2 diabetes to renal biopsy and the proportion of biopsies with any diabetic nephropathy (DN) and any non-diabetic.
Box-and-whisker plots of SMAP assessed by AUC in diabetic patients with normoalbuminuria and albuminuria, treated with or without aspirin. Box-and-whisker.
Kaplan-Meier survival (renal event-free) curves during follow-up by tertiles of plasma copeptin. Kaplan-Meier survival (renal event-free) curves during.
Complex association between Hb level and GFR, sex, and AER
GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A:
Relative renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category and typical mode of clinical.
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Presentation transcript:

Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function Featured Article: Elif I. Ekinci, P.H.D., George Jerums, M.D., Alison Skene, M.B.B.S., Paul Crammer, B.A.P.P.S.C., David Power, P.H.D., Karey Y. Cheong, B.S.C., Sianna Panagiotopoulos, P.H.D., Karen McNeil, M.B.B.S., Scott T. Baker, M.B.B.S., Paola Fioretto, M.D., Richard J. MacIsaac, P.H.D., Diabetes Care Volume 36: November, 2013

STUDY OBJECTIVE To compare renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measure GFR of <60 mL/min/1.73 m2, associated with normo-, micro-, or macroalbuminuria Ekinci E. I. et al. Diabetes Care 2013;36:

STUDY DESIGN AND METHODS In patients with normo- or microalbuminuria, renal biopsies were performed according to a research protocol In patients with macroalbuminuria, biopsies were performed according to clinical indication Findings were categorized according to the Fioretto classification: Category 1 (C1): normal/near normal Category 2 (C2): typical diabetic nephropathy (DN) with predominantly glomerular changes Category 3 (C3): atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes Ekinci E. I. et al. Diabetes Care 2013;36:

RESULTS Typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria Predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria Varying degrees of arteriosclerosis were seen in seven of eight subjects with normoalbuminuria Ekinci E. I. et al. Diabetes Care 2013;36:

CONCLUSIONS Typical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria In normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis Ekinci E. I. et al. Diabetes Care 2013;36: